These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 7638701)
1. Incidence of HIV infection in first-time blood donors. Buckle GC; Webb GL S Afr Med J; 1995 May; 85(5):396-7. PubMed ID: 7638701 [No Abstract] [Full Text] [Related]
2. Residual risk of transmission of HIV through blood transfusion in South Africa. Sitas F; Fleming AF; Morris J S Afr Med J; 1994 Mar; 84(3):142-4. PubMed ID: 7740349 [TBL] [Abstract][Full Text] [Related]
3. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [TBL] [Abstract][Full Text] [Related]
4. Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa. Nagalo BM; Bisseye C; Sanou M; Kienou K; Nebié YK; Kiba A; Dahourou H; Ouattara S; Nikiema JB; Moret R; Zongo JD; Simpore J Trop Med Int Health; 2012 Feb; 17(2):247-53. PubMed ID: 21988100 [TBL] [Abstract][Full Text] [Related]
5. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services. O'Brien SF; Yi QL; Fan W; Scalia V; Fearon MA; Allain JP Vox Sang; 2012 Jul; 103(1):83-6. PubMed ID: 22289147 [TBL] [Abstract][Full Text] [Related]
6. Risk of HIV infection from blood transfusion in Montreal. Remis RS; Delage G; Palmer RW CMAJ; 1997 Aug; 157(4):375-82. PubMed ID: 9275944 [TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus prevalence, incidence, and residual transmission risk in first-time and repeat blood donations in Zimbabwe: implications on blood safety. Mapako T; Mvere DA; Chitiyo ME; Rusakaniko S; Postma MJ; van Hulst M Transfusion; 2013 Oct; 53(10 Pt 2):2413-21. PubMed ID: 23789991 [TBL] [Abstract][Full Text] [Related]
8. The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection. Kleinman S; Busch MP; Korelitz JJ; Schreiber GB Transfus Med Rev; 1997 Jul; 11(3):155-72. PubMed ID: 9243769 [No Abstract] [Full Text] [Related]
9. Residual risk of transfusion transmitted viral infections among seronegative donors: application of the incidence/window period model. Kleinman S Dev Biol (Basel); 2000; 102():61-5. PubMed ID: 10794091 [No Abstract] [Full Text] [Related]
10. Profile of transfusion transmissible infections and associated risk factors among blood donors of Kerala. Mathai J; Sulochana PV; Satyabhama S; Nair PK; Sivakumar S Indian J Pathol Microbiol; 2002 Jul; 45(3):319-22. PubMed ID: 12785175 [TBL] [Abstract][Full Text] [Related]
11. Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review. Cable R; Lelie N; Bird A Vox Sang; 2013 Feb; 104(2):93-9. PubMed ID: 22924987 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios. Bruhn R; Lelie N; Custer B; Busch M; Kleinman S; Transfusion; 2013 Oct; 53(10 Pt 2):2399-412. PubMed ID: 23782054 [TBL] [Abstract][Full Text] [Related]
13. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. Al Shaer L; AbdulRahman M; John TJ; AlHashimi A Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239 [TBL] [Abstract][Full Text] [Related]
14. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy. Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219 [TBL] [Abstract][Full Text] [Related]
15. Risk of HIV transmission through blood transfusions is decreasing. N Y State J Med; 1989 Dec; 89(12):695-6. PubMed ID: 2594269 [No Abstract] [Full Text] [Related]
16. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779 [TBL] [Abstract][Full Text] [Related]
17. [A retrospective study of the practice of "look-back" procedures, on the incidence of HIV-1/2-positive blood donors and the risk of transfusion-associated HIV infection in public-community blood banks in Germany]. Zeiler T; Kretschmer V; Sibrowski W Infusionsther Transfusionsmed; 1994 Dec; 21(6):362-7. PubMed ID: 7873914 [TBL] [Abstract][Full Text] [Related]
18. [Prevalence and incidence of HIV and hepatitis B among blood donors and estimated residual risk of transmission of HIV and HBV virus by blood transfusion. A study at the Provincial General Referee Hospital Bukavu, Democratic Republic of the Congo]. Namululi BA; Guerrieri C; Dramaix MW Rev Epidemiol Sante Publique; 2013 Apr; 61(2):139-44. PubMed ID: 23498094 [TBL] [Abstract][Full Text] [Related]
19. Transfusion-transmitted human immunodeficiency virus infection by a Danish blood donor with a very low viral load in the preseroconversion window phase. Harritshoj LH; Dickmeiss E; Hansen MB; Ullum H; Jorgensen LB; Gerstoft J Transfusion; 2008 Sep; 48(9):2026-8. PubMed ID: 18811898 [No Abstract] [Full Text] [Related]
20. [Comments to the manuscript; HIV in Mexican blood donors and estimated transfusional risk]. Sánchez-Guerrero SA Rev Invest Clin; 2008; 60(6):545-6; author reply 547. PubMed ID: 19378840 [No Abstract] [Full Text] [Related] [Next] [New Search]